First Issue of AIChE/SBE "Bioengineering and Translational Medicine" Open Access Journal Now Online

Special issue focuses on the targeting, optimization and clinical applications of nanoparticles
July 20, 2016

Bioengineering & Translational Medicine (BioTM), published by Wiley in partnership with the American Institute of Chemical Engineers (AIChE) and its Society for Biological Engineering (SBE), has released its first issue. The special issue, entitled “Nanoparticles in Medicine: Targeting, Optimization and Clinical Applications,” is freely available to read, download and share from Wiley Online Library.

The last decade has seen robust research on the use of nanoparticles for drug delivery and imaging. A number of nanoparticles are currently under clinical trials, showing the great strides being undertaken to translate nanoparticles into clinical practice. Composed of seven manuscripts, this issue highlights such groundbreaking efforts, with a special focus on strategies that enhance the value of nanoparticles in oncological and cardiovascular disease treatments. Contributions cover topics ranging from engineering nanoparticle properties for immunotherapy to maximizing the cytotoxic effect of gold nanoparticles on colon cancer.

Edited by Senior Researcher and Professor Paolo Decuzzi of the Italian Institute of Technology and BioTM’s Editor-in-Chief Samir Mitragotri of the University of California, Santa Barbara, “Nanoparticles in Medicine” is a collection of research essential to understanding and overcoming the challenges in translating nanoparticles into clinical practice. Read it for free on www.bioengtransmed.com.

Launched in November 2015, BioTM is AIChE and SBE’s first open access journal, providing global and free access to high-quality innovative research on the clinical translation of biological engineering principles. The journal invites research reports, reviews and rapid communications covering drug delivery, drug discovery, tissue engineering, synthetic biology, gene therapy, computational modeling and bioinformatics. All contributions are published under the CC-BY Creative Commons license. Visit the journal website (http://www.bioengtransmed.com) for more information. Submit manuscripts to http://mc.manuscriptcentral.com/btm. 

About SBE:

Established in 2004, the Society for Biological Engineering is a technological community for engineers and applied scientists integrating biology with engineering. Members of SBE come from a broad spectrum of industries and disciplines and share in SBE’s mission of realizing the benefits of bioprocessing, biomedical and biomolecular applications. http://bio.aiche.org.

About AIChE:

AIChE is a professional society of more than 53,000 chemical engineers in 110 countries. Its members work in corporations, universities and government using their knowledge of chemical processes to develop safe and useful products for the benefit of society. Through its varied programs, AIChE continues to be a focal point for information exchange on the frontiers of chemical engineering research in such areas as energy, sustainability, biological and environmental engineering, nanotechnology and chemical plant safety and security. More information about AIChE is available at http://www.aiche.org.

About Wiley:

Wiley is a global provider of knowledge and knowledge-enabled services that improve outcomes in areas of research, professional practice and education. Through the Research segment, the Company provides digital and print scientific, technical, medical, and scholarly journals, reference works, books, database services, and advertising. The Professional Development segment provides digital and print books, online assessment and training services, and test prep and certification. In Education, Wiley provides education solutions including online program management services for higher education institutions and course management tools for instructors and students, as well as print and digital content. The company's website can be accessed at www.wiley.com.